About: Chemo-enzymatic synthesis of LacdiNAc dimers of varying length as novel galectin ligands     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • A set of sixteen bivalent symmetrical and asymmetrical LacdiNAc dimers containing flexible alkyl linkers were efficiently synthesized by means of chemo-enzymatic synthesis, using the versatile potential of the Y284L mutant of human placental beta 1,4-galactosyltransferase-1. LacdiNAc was confirmed to be a specific ligand for human galectin-3 contrary to human galectin-1. The compounds were tested as ligands for human galectin-3 in competitive binding assays and compared to a monovalent LacdiNAc standard. Molecular modeling was performed to calculate approximate length of respective ligands and its relation to their inhibitory capacity. The best performance was observed in symmetrical compounds carrying two LacdiNAc units connected with a hydrophobic linker of sufficient length (alkyl chain n >= 6). Here, the IC50 value was about three times lower than that of the monovalent standard. Our results propose that hydrophobicity directed by the alkyl chain length as well as the specificity and bivalency of the LacdiNAc contribute to the inhibition potential of these ligands. Though only slightly pronounced in this case, higher multivalency is a promising feature in the design of optimized ligands for galectin-3
  • A set of sixteen bivalent symmetrical and asymmetrical LacdiNAc dimers containing flexible alkyl linkers were efficiently synthesized by means of chemo-enzymatic synthesis, using the versatile potential of the Y284L mutant of human placental beta 1,4-galactosyltransferase-1. LacdiNAc was confirmed to be a specific ligand for human galectin-3 contrary to human galectin-1. The compounds were tested as ligands for human galectin-3 in competitive binding assays and compared to a monovalent LacdiNAc standard. Molecular modeling was performed to calculate approximate length of respective ligands and its relation to their inhibitory capacity. The best performance was observed in symmetrical compounds carrying two LacdiNAc units connected with a hydrophobic linker of sufficient length (alkyl chain n >= 6). Here, the IC50 value was about three times lower than that of the monovalent standard. Our results propose that hydrophobicity directed by the alkyl chain length as well as the specificity and bivalency of the LacdiNAc contribute to the inhibition potential of these ligands. Though only slightly pronounced in this case, higher multivalency is a promising feature in the design of optimized ligands for galectin-3 (en)
Title
  • Chemo-enzymatic synthesis of LacdiNAc dimers of varying length as novel galectin ligands
  • Chemo-enzymatic synthesis of LacdiNAc dimers of varying length as novel galectin ligands (en)
skos:prefLabel
  • Chemo-enzymatic synthesis of LacdiNAc dimers of varying length as novel galectin ligands
  • Chemo-enzymatic synthesis of LacdiNAc dimers of varying length as novel galectin ligands (en)
skos:notation
  • RIV/61388971:_____/14:00428358!RIV15-GA0-61388971
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, P(GAP207/11/0629), P(LD13042)
http://linked.open...iv/cisloPeriodika
  • MAR 2014
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 7113
http://linked.open...ai/riv/idVysledku
  • RIV/61388971:_____/14:00428358
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Galectin; Galactosyltransferase; Multivalency (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • NL - Nizozemsko
http://linked.open...ontrolniKodProRIV
  • [9ACD6FD3AA6C]
http://linked.open...i/riv/nazevZdroje
  • Journal of Molecular Catalysis B-Enzymatic
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 101
http://linked.open...iv/tvurceVysledku
  • Bojarová, Pavla
  • Elling, L.
  • Hofbauerová, Kateřina
  • Křen, Vladimír
  • Pelantová, Helena
  • Müller, A.
  • Kupper, E. Ch.
  • Bӧcker, S.
  • Šimonová, Anna
http://linked.open...ain/vavai/riv/wos
  • 000332142400008
issn
  • 1381-1177
number of pages
http://bibframe.org/vocab/doi
  • 10.1016/j.molcatb.2013.12.018
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software